The process of wound healing is intricate and regulated by a network of cellular, molecular, and biochemical pathways. Acute wounds progress via distinct phases of hemostasis, inflammation, proliferation, and remodeling. Chronic wounds frequently cease to heal and exhibit resistance to conventional therapies. These types of injuries are frequently attributed to diabetes, infection, or senescence. Existing therapies are constrained due to their ineffectiveness against bacteria, inability to promote regeneration, and inadequate control over medication release. Nanotechnology presents novel methods to overcome these challenges by providing multifunctional platforms that enable biological repair and medicinal delivery. Nanoparticles, which combat germs and modulate the immune system, in addition to being intelligent carriers that react to pH, oxidative stress, or enzymatic activity, provide targeted and adaptive wound therapy. Nanocomposite hydrogels are particularly advantageous as biointeractive dressings due to their ability to maintain wound moisture while facilitating regulated drug delivery. Recent advancements indicate their potential to aid in tissue regeneration, enhance therapy precision, and address issues related to safety and translation. Nanotechnology-based approaches, especially smart hydrogels, give significant promise to transform the future of wound care due to their flexibility, adaptability, and efficiency.
Aliyev et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: